Hemorrhagic vesiculobullous eruption on the palms and the soles as presentation of dyshidrosiform bullous pemphigoid by A. Michelerio et al.
CASE REPORTFrom the
Science
Patholo
sity of
Funding s
Conflicts o
Correspon
Fondaz
27100
smatteHemorrhagic vesiculobullous eruption
on the palms and the soles aspresentation of dyshidrosiform bullous
pemphigoid
Andrea Michelerio, MD,a Giorgio Alberto Croci, MD,b Camilla Vassallo, MD, PhD,a and
Valeria Brazzelli, MDa
Pavia, ItalyKey words: bullous pemphigoid; bullous tinea pedis; dyshidrosiform pemphigoid; pompholyx.Abbreviations used:
BP: bullous pemphigoid
DP: dyshidrosiform pemphigoidINTRODUCTION
Dyshidrosiform bullous pemphigoid (DP) is an
unusual localized variant of bullous pemphigoid
(BP), first described by Levine et al1 in 1979. It
presents with a persistent and recurrent vesicobul-
lous eruption, sometimes hemorrhagic, localized to
the soles and/or palms. Since the clinical manifesta-
tions of DP are similar to those of pompholyx or
bullous tinea pedis, which are more common and
benign dermatologic diseases, a proper diagnosis
could be delayed. We report the case of an 82-year-
old man affected by DP who was treated for months
for pompholyx and bullous tinea pedis with derma-
tophytid reaction.
CASE REPORT
An 82-year-old man presented with a few-months’
history of recurrent itchy vesicobullous eruption
localized to the soles and the palms. First diagnosed
in another center with pompholyx, the patient was
treated with topical betamethasone with temporary
benefit, but the symptoms soon recurred. Direct
microscopic examination of a potassium hydroxide
preparation and the fungal culture of skin scrapings
yielded positive results, and a diagnosis of bullous
tinea pedis with dermatophytid reaction was made.
Although 1-month therapy with daily itraconazole
100 mg, potassium permanganate solution 1 in
10,000 soaks, chlorquinaldol 2% in petrolatum, and
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o.pv.it.improvement was noted. When the patient pre-
sented to our clinic, multiple tense vesiculobullae
(some hemorrhagic) on the nonerythematous skin of
the palms, the soles, and lateral surfaces of both
hands and feet were present (Fig 1). No mucosal or
other cutaneous involvement was observed, and the
Nikolsky sign was negative. Mycologic examination
with potassium hydroxide preparation and a fungal
culture from skin scrapings found no trace of fungal
elements. The patient denied consistent exposure to
allergens or products that might induce persistent
contact dermatitis. A skin biopsy from the lateral foot
skin was performed. The histopathologic finding
revealed focal spongiosis tending to form focally
subepidermal clefts and a predominantly eosino-
philic dermal infiltration, which is consistent with
early BP lesions (Fig 2). Direct immunofluorescence
of the perilesional skin disclosed continuous linear
deposits of IgG along the dermoepidermal junction
and blister roof staining within separate portions of
biopsy (Fig 3). An enzyme-linked immunosorbent
assay found circulating antibodies to BP180 (71.0 U/
mL; normal values,\9 U/mL) and BP230 (85.2 U/mL;
normal values, \9 U/mL). A diagnosis of DP wasJAAD Case Reports 2018;4:61-3.
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Fig 1. Multiple tense vesiculobullae of dyshidrosiform
pemphigoid, some of them hemorrhagic, on nonerythem-
atous skin on the soles and the lateral surfaces of feet.
Fig 2. Histopathologic findings show focal spongiosis
tending to form focally subepidermal clefts and a pre-
dominantly eosinophilic dermal infiltration, consistent
with bullous pemphigoid. (Hematoxylin-eosin stain; orig-
inal magnification: 320.) A high-resolution version of this
slide for use with the Virtual Microscope is available as
eSlide: VM04193.
Fig 3. Direct immunofluorescence of the perilesional skin
shows continuous linear deposits of IgG along the
dermoepidermal junction, consistent with bullous pem-
phigoid. Note the staining pattern of the blister roof within
separate portions of biopsy, further supporting BP
diagnosis.
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thasone and prednisone 50 mg/day, which resulted
in a marked clinical improvement with no new
blister formation. The systemic steroid dose was
then gradually tapered. Eight months later, the
patient remains in good condition.DISCUSSION
DP is a rare variant of localized BP, which Levine
et al1 first reported in 1979. It presents with a
persistent and recurrent vesicobullous eruption local-
ized to the soles and/or palms, often misleadingclinicians to diagnose pompholyx or bullous tinea
pedis.2 When present, the hemorrhagic character of
the bullae could be an important clue for dermatol-
ogists,3 but only a skin biopsy revealing the typical
pathologic hallmarks of BP,2,4 direct immunofluores-
cence, and the assays for the evaluation of circulating
antibodies to BP180 and BP230 allowed a correct
diagnosis. To the best of our knowledge, only 31
cases of DP have been reported in the literature so far.
However, since the diagnosis of DP may be
misleading, the disease prevalence could have been
underestimated. In a clinical report by Chang et al,5 3
of 86 patients with BP could have a dyshidrosiform
type. Most of the cases of DP are described in elderly
patients, but Caldarola et al6 and Lupi et al7 reported 2
cases in young adults. DP’s pathologic mechanism is
currently unknow. Levine et al1 proposed that an
inflammatory process, such as tinea pedis, could
uncover antigens usually protected from antibody
recognition. Interestingly, our patient reported traces
of a fungal infection only in the first mycologic
examination. The first result may have been a false-
positive, or the oral itraconazole treatment may have
led to the infection resolution. According to the
literature, mycologic research has been performed
only in 2 other reported cases, both with negative
results.6,7 Therefore, further studies are needed to
determine the disease’s exact pathogenesis. Initially
reported as a localized variant of BP, it has been
shown that DP may precede or occur concomitantly
with generalized lesions of classic BP, ranging from
urticarial plaques to bullae and erosions.3,7,8
Consequently, a follow-up examination ismandatory.
DP has generally proved very responsive to topical
steroids, at least temporarily. This fact may also have
contributed to underdiagnosis, as cases that respond
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furtherworkupwith biopsy and immunofluorescence
studies. Although low-dose oral steroid therapy has
been used primarily for systemic treatment, other
therapies include dapsone, cyclophosphamide,
azathioprine, methotrexate, and erythromycin. The
condition has subsided in all cases reported in the
literature as well as in our patient.
In conclusion, clinicians should be aware that an
unusually persistent or recurrent pompholyx-like
eruption on the palms and/or the soles, especially
if hemorrhagic and particularly in elderly patients,
may conceal BP.
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